|
24399
|
Taurine Volbloed
|
|
EDTA (diepgevroren) |
1x per week |
189 (7,9) |
–
|
—
µmol/L |
—
|
› |
|
24420
|
Toxoplasma IgM zwanger
Panel
Toxoplasmose
|
|
Serum |
|
2 (0,1) |
–
|
—
|
—
|
› |
|
24421
|
Toxoplasma IgG zwanger
Panel
Toxoplasmose
|
|
Serum |
|
2 (0,1) |
–
|
—
|
—
|
› |
|
24422
|
CMV IgM zwanger
Panel
CMV IgM (zwanger)
|
|
Serum |
|
2 (0,1) |
–
|
—
|
—
|
› |
|
24423
|
CMV IgG zwanger
Panel
CMV IgG (zwanger)
|
|
Serum |
|
2 (0,1) |
–
|
—
|
—
|
› |
|
24424
|
Toxo IgM zw./infectie?
Panel
Toxoplasmose
|
|
Serum |
|
2 (0,1) |
–
|
—
|
—
|
› |
|
24425
|
Toxo IgG zw./infectie?
Panel
Toxoplasmose
|
|
Serum |
|
2 (0,1) |
–
|
—
|
—
|
› |
|
24426
|
CMV IgM zw./infectie?
Panel
CMV IgM (zwanger/infectie?)
|
|
Serum |
|
2 (0,1) |
–
|
—
|
—
|
› |
|
24428
|
CMV IgG zw./infectie?
Panel
CMV IgG (zwanger/infectie?)
|
|
Serum |
|
2 (0,1) |
–
|
—
|
—
|
› |
|
24435
|
Legionella pneumon.
Panel
|
|
Serum |
|
305 (12,7) |
–
|
—
|
—
|
› |
|
24453
|
Vaccicheck kat/hond
|
|
Serum |
1x per week |
22 (0,9) |
–
|
—
|
—
|
› |
|
24455
|
Neospora canine
Panel
Neospora (hond)
|
|
Serum |
|
163 (6,8) |
–
|
—
|
—
|
› |
|
24460
|
Hepatitis B surface Ag
Australia antigeen, HBsAg
|
|
Serum |
Dagelijks |
2 (0,1) |
B
|
5195-3
Index |
—
|
› |
|
24462
|
Hepatitis B e antigeen
HBeAg
|
|
Serum |
Maandag t/m vrijdag |
2 (0,1) |
B
|
31844-4
Index |
—
|
› |
|
24464
|
Hepatitis Be antistoffen
HBeAs
|
|
Serum |
Maandag t/m vrijdag |
3 (0,1) |
B
|
22320-6
Index |
—
|
› |
|
24466
|
Hepatitis B core As
HBcAs
|
|
Serum |
Dagelijks |
2 (0,1) |
B
|
16933-4
Index |
—
|
› |
|
24469
|
HBsAg confirmatie
Panel
Hepatitis B s Ag neutralisatie
|
|
Serum |
|
42 (1,8) |
–
|
63557-3
|
—
|
› |
|
24493
|
Hepatitis B surface As
HBV surface antistoffen
|
|
Serum |
Dagelijks |
2 (0,1) |
B
|
16935-9
mIU/mL |
—
|
› |
|
24496
|
anti-HBs na 4 weken
HBV surface antistoffen na 4 weken
|
|
Serum |
Dagelijks |
1 (0) |
B
|
—
mIU/mL |
—
|
› |
|
24497
|
anti-HBs voor booster
HBV surface antistoffen voor booster
|
|
Serum |
|
1 (0,1) |
B
|
—
mIU/mL |
—
|
› |
|
24499
|
anti-HBs na booster
HBV surface antistoffen na booster
|
|
Serum |
|
1 (0,1) |
B
|
—
mIU/mL |
—
|
› |
|
24501
|
Hepatitis A IgM (recent)
HAV IgM antistoffen
|
|
Serum |
Dagelijks |
2 (0,1) |
B
|
22315-6
Index |
22314-9
Index |
› |
|
24503
|
Hepatitis A As (totaal)
HAVAB
|
|
Serum |
Dagelijks |
2 (0,1) |
B
|
22312-3
Index |
32018-4
Index |
› |
|
24506
|
anti-HBs na booster 5
|
|
Serum |
|
1 (0) |
–
|
—
mIU/mL |
—
|
› |
|
24507
|
Hepatitis C antistoffen
HCV antistoffen, HCV As
|
|
Serum |
Dagelijks |
2 (0,1) |
B
|
16128-1
Index |
—
|
› |
|
24510
|
EBV Monospot
Epstein-Barr Virus Monospot, Heterofiele antistoffen, Paul-Bunnell
|
|
Serum |
Dagelijks |
5 (0,2) |
B
|
94149-2
|
—
|
› |
|
24524
|
Epstein-Barr EA (D) IgG
EBV EA IgG antistoffen, EBV early antigen IgG antistoffen
|
|
Serum |
Maandag t/m Zaterdag |
48 (2) |
–
|
24007-7
U/ml |
—
|
› |
|
24527
|
Epstein-Barr VCA IgM
EBV IgM
|
|
Serum |
Dagelijks |
2 (0,1) |
B
|
7886-5
Index |
30340-4
Index |
› |
|
24537
|
Epstein-Barr NA IgG
Epstein-Barr nuclear antigen IgG
|
|
Serum |
Dagelijks |
2 (0,1) |
B
|
31374-2
Index |
7883-2
Index |
› |
|
24544
|
CMV IgM
CMV IgM
|
|
Serum |
Dagelijks |
1 (0,1) |
B
|
7853-5
Index |
—
|
› |
|
24545
|
CMV IgG
CMV IgG
|
|
Serum |
Dagelijks |
1 (0,1) |
B
|
7852-7
IU/mL |
—
|
› |
|
24546
|
Rubella IgM
|
|
Serum |
Dagelijks |
1 (0,1) |
B
|
8015-0
Index |
—
|
› |
|
24547
|
Rubella IgG vrouw
|
|
Serum |
Dagelijks |
1 (0,1) |
B
|
8014-3
IU/mL |
—
|
› |
|
24574
|
Rubella bevestiging
Panel
|
|
Serum |
|
20 (0,8) |
–
|
—
|
—
|
› |
|
24585
|
HSV type 1-2 immunoblot
Panel
Herpes simplex IgG type 1, Herpes simplex IgG type 2, HSV IgG type 1-2 differentiatie
|
|
Serum |
|
257 (10,7) |
–
|
81621-5
|
—
|
› |
|
24589
|
SARS-CoV-2-S antistoffen
Coronavirus 19, COVID-19, Severe Acute Respiratory Syndrome
|
|
Serum |
Dagelijks |
24 (1) |
–
|
94505-5
U/mL |
—
|
› |
|
24610
|
Mazelen IgM
|
|
Serum |
Tenminste 1x per week |
89 (3,7) |
B
|
25421-9
index |
—
|
› |
|
24611
|
Anti-Mazelen IgG
|
|
Serum |
3x per week |
58 (2,4) |
B
|
7962-4
IU/L |
7962-4
mIU/mL |
› |
|
24616
|
Bof IgM
|
|
Serum |
Tenminste 2x per week |
106 (4,4) |
B
|
25419-3
index |
—
|
› |
|
24624
|
Bof IgG
|
|
Serum |
Tenminste 2x per week |
113 (4,7) |
B
|
7966-5
U/mL |
22417-0
U/mL |
› |
|
24645
|
SARS-CoV-2-N-IgG/IgM
Coronavirus 19, COVID-19, Severe Acute Respiratory Syndrome
|
|
Serum |
Dagelijks |
68 (2,8) |
–
|
—
COI |
—
|
› |
|
24646
|
Ratio SARS-CoV-2 S/N IgG
ƒ
|
|
Serum |
Dagelijks |
n.v.t. |
–
|
—
(LogU/ml)/(COI) |
—
|
› |
|
24647
|
Ratio SARS-CoV-2 S/N IgG
Panel
Coronavirus 19, COVID-19, Severe Acute Respiratory Syndrome
|
|
Serum (2×) |
|
72 (3) |
–
|
—
|
—
|
› |
|
24653
|
Enterovirus antistoffen
Panel
Coxsackievirus As, Echovirus As, Enterovirus As
|
|
Serum |
|
308 (12,8) |
–
|
—
|
—
|
› |
|
24660
|
Herpes simplex IgM
HSV IgM
|
|
Serum |
2x per week |
87 (3,6) |
B
|
43030-6
index |
—
|
› |
|
24662
|
Herpes simplex IgG
HSV IgG
|
|
Serum |
2x per week |
85 (3,5) |
B
|
31411-2
RU/mL |
—
|
› |
|
24670
|
Varicella zoster IgM
Herpes zoster IgM, VZV IgM
|
|
Serum |
Maandag t/m Zaterdag |
23 (1) |
B
|
5404-9
Index |
—
|
› |
|
24671
|
Varicella zoster IgG
|
|
Serum |
Maandag t/m Zaterdag |
23 (1) |
B
|
8047-3
mIU/mL |
—
|
› |
|
24710
|
Parvovirus B19 IgM
|
|
Serum |
Maandag t/m Zaterdag |
24 (1) |
B
|
7984-8
Index |
—
|
› |
|
24712
|
Parvovirus B19 IgG
|
|
Serum |
Maandag t/m Zaterdag |
24 (1) |
B
|
7983-0
IU/mL |
—
|
› |
